OSAM
DTIL icon

O'Shaughnessy Asset Management’s Precision BioSciences DTIL Stock Holding History

O'Shaughnessy Asset Management’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-234
Closed -$81K – 1576
2021
Q3 		$81K Buy
+234
New +$79.3K ﹤0.01% 1456

Other funds holding DTIL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
OMC
OUP Management Company Bala Cynwyd, Pennsylvania $44.5M AUM 55.11% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

O'Shaughnessy Asset Management's DTIL Position: Q4 2021 in Review

O'Shaughnessy Asset Management sold out of Precision BioSciences (DTIL) in Q4 2021, closing a stake of 234 shares — an estimated $81K sold.

O'Shaughnessy Asset Management first reported a position in DTIL in Q3 2021 and held it in 1 quarter. The position peaked at $81K in Q3 2021. 134 funds tracked by Wall St. Rank hold DTIL as of Q4 2021.

  • O'Shaughnessy Asset Management reported no remaining Precision BioSciences position as of Q4 2021 after selling out during the quarter.
  • O'Shaughnessy Asset Management sold 234 Precision BioSciences shares in Q4 2021, an estimated $81K.
  • O'Shaughnessy Asset Management first reported a position in Precision BioSciences in Q3 2021 and held it in 1 quarter.
  • O'Shaughnessy Asset Management's Precision BioSciences position peaked at $81K in Q3 2021.
  • 134 funds tracked by Wall St. Rank held Precision BioSciences as of Q4 2021.

Based on O'Shaughnessy Asset Management's 13F filing for Q4 2021, filed 11 Feb 2022.